Migalastat Efficient in Female Patients With Fabry Disease Fabry disease is severe and causes considerable burden in female patients and migalastat is efficient in the long term in these patients.

#FabryDisease is severe and causes considerable burden in female patients, according to a study that appeared in the Journal of Medical Genetics. The study also showed that #Migalastat is efficient in the long term in these patients.

Learn more: https://bit.ly/3KB4ahQ

#RareDisease #MedSky #RareSky